Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040404
Status:
TERMINATED
Last Update Posted:
2012-05-10
First Post:
2002-06-26
Brief Title:
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinsons Disease
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Dose-Finding Study to Assess the Efficacy and Safety of CEP-1347 in Patients With Parkinsons Disease
Status:
TERMINATED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Unlikely to provide evidence of significant effect
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to establish safety for CEP-1347 and to determine an efficacious dose in the treatment of Parkinsons disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None